Loading…
Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens
Abstract Membrane vesicles (MVs), discrete nano-structures produced from the outer membrane of Gram-negative bacteria such as Salmonella enterica Typhimurium ( S. Typhimurium), strongly activate dendritic cells (DCs), contain major antigens (Ags) recognized by Salmonella -specific B-cells and CD4+ T...
Saved in:
Published in: | Vaccine 2015-09, Vol.33 (38), p.5012-5019 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243 |
---|---|
cites | cdi_FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243 |
container_end_page | 5019 |
container_issue | 38 |
container_start_page | 5012 |
container_title | Vaccine |
container_volume | 33 |
creator | Laughlin, Richard C Mickum, Megan Rowin, Kristina Adams, L. Garry Alaniz, Robert C |
description | Abstract Membrane vesicles (MVs), discrete nano-structures produced from the outer membrane of Gram-negative bacteria such as Salmonella enterica Typhimurium ( S. Typhimurium), strongly activate dendritic cells (DCs), contain major antigens (Ags) recognized by Salmonella -specific B-cells and CD4+ T-cells, and provide protection against S. Typhimurium challenge in a mouse model. With this in mind, we hypothesized that alterations to the gene expression profile of bacteria will be reflected in the immunologic response to MVs. To test this, we assessed the ability of MVs from wild-type (WT) S. Typhimurium or a strain with a phenotype mimicking the intracellular-phase of S. Typhimurium (PhoPc ) to activate dendritic cells and initiate a strong inflammatory response. MVs, isolated from wild-type and PhoPc S. Typhimurium (WT MVs andPhoPc MVs, respectively) had pro-inflammatory properties consistent with the parental bacterial strains:PhoPc MVs were less stimulatory for DC activation in vitro and were impaired for subsequent inflammatory responses compared toWT MVs. Interestingly, the reduced pro-inflammatory properties ofPhoPc MVs did not completely rely on signals through TLR4, the receptor for LPS. Nonetheless, bothWT MVs andPhoPc MVs contained abundant immunogenic antigens capable of being recognized by memory-immune CD4+ T-cells from mice previously infected with S. Typhimurium. Furthermore, we analyzed a suite of pathogenic Gram-negative bacteria and their purified MVs for their ability to activate DCs and stimulate inflammation in a manner consistent with the known inflammatory properties of the parental strains, as shown for S. Typhimurium. Finally, analysis of the potential vaccine utility of S. Typhimurium MVs revealed their capacity to encapsulate an exogenous model antigen and stimulate antigen-specific CD4+ and CD8+ T-cell responses. Taken together, our results demonstrate the dependence of bacterial cell gene expression for MV immunogenicity and subsequent in vitro immunologic response, as well as their potential utility as a vaccine platform. |
doi_str_mv | 10.1016/j.vaccine.2015.05.014 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1717495437</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X15006350</els_id><sourcerecordid>3798264231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243</originalsourceid><addsrcrecordid>eNqNkk9r3DAQxUVpaTZ_PkKLoZdcvB1JlmxfWkJo0kKgh7SQU4QsjxNtLWkr2Qv59pXZbQu5tDAgGH56eqM3hLyhsKZA5fvNeqeNsR7XDKhYQy5avSAr2tS8ZII2L8kKmKzKisLdETlOaQMAgtP2NTliEjLN2YrcX4wTRuyLx5Cmwjo3eywipm3wCVMxhcKh66LO3R0ma8bcHGJwxa0eXfA4jrrQvi-uo3alxwc92R0WWz09hgf06ZS8GvSY8OxwnpDvV5--XX4ub75ef7m8uCmNEHQqKw201ig6bFH0HQ5c8F6Aboe6NQ00sjFN1bWi5azTYCSXsmYghnZomEFW8RNyvtfdxvBzxjQpZ5NZ3HkMc1K0pnXViorX_4OCFEJwltF3z9BNmKPPg2QK2mydUZopsadMDClFHNQ2Wqfjk6KglqzURh2yUktWCnLRxfPbg_rcOez_3PodTgY-7gHMP7ezGFUyFr3B3kY0k-qD_ecTH54pmNF6a_T4A58w_Z1GJaZA3S4Ls-wLFQCSC-C_AJQyu-o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1709551211</pqid></control><display><type>article</type><title>Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens</title><source>ScienceDirect Journals</source><creator>Laughlin, Richard C ; Mickum, Megan ; Rowin, Kristina ; Adams, L. Garry ; Alaniz, Robert C</creator><creatorcontrib>Laughlin, Richard C ; Mickum, Megan ; Rowin, Kristina ; Adams, L. Garry ; Alaniz, Robert C</creatorcontrib><description>Abstract Membrane vesicles (MVs), discrete nano-structures produced from the outer membrane of Gram-negative bacteria such as Salmonella enterica Typhimurium ( S. Typhimurium), strongly activate dendritic cells (DCs), contain major antigens (Ags) recognized by Salmonella -specific B-cells and CD4+ T-cells, and provide protection against S. Typhimurium challenge in a mouse model. With this in mind, we hypothesized that alterations to the gene expression profile of bacteria will be reflected in the immunologic response to MVs. To test this, we assessed the ability of MVs from wild-type (WT) S. Typhimurium or a strain with a phenotype mimicking the intracellular-phase of S. Typhimurium (PhoPc ) to activate dendritic cells and initiate a strong inflammatory response. MVs, isolated from wild-type and PhoPc S. Typhimurium (WT MVs andPhoPc MVs, respectively) had pro-inflammatory properties consistent with the parental bacterial strains:PhoPc MVs were less stimulatory for DC activation in vitro and were impaired for subsequent inflammatory responses compared toWT MVs. Interestingly, the reduced pro-inflammatory properties ofPhoPc MVs did not completely rely on signals through TLR4, the receptor for LPS. Nonetheless, bothWT MVs andPhoPc MVs contained abundant immunogenic antigens capable of being recognized by memory-immune CD4+ T-cells from mice previously infected with S. Typhimurium. Furthermore, we analyzed a suite of pathogenic Gram-negative bacteria and their purified MVs for their ability to activate DCs and stimulate inflammation in a manner consistent with the known inflammatory properties of the parental strains, as shown for S. Typhimurium. Finally, analysis of the potential vaccine utility of S. Typhimurium MVs revealed their capacity to encapsulate an exogenous model antigen and stimulate antigen-specific CD4+ and CD8+ T-cell responses. Taken together, our results demonstrate the dependence of bacterial cell gene expression for MV immunogenicity and subsequent in vitro immunologic response, as well as their potential utility as a vaccine platform.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2015.05.014</identifier><identifier>PMID: 26001432</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Allergy and Immunology ; Animals ; Bacteria ; Bacterial Vaccines - immunology ; Bacteriology ; CD4-Positive T-Lymphocytes - immunology ; CD8-Positive T-Lymphocytes - immunology ; Cell-Derived Microparticles - immunology ; Colleges & universities ; Conflicts of interest ; Dendritic cell ; Dendritic Cells - immunology ; Female ; Gene expression ; Genetic engineering ; Gram-negative bacteria ; Immunity, Innate ; Immunogenicity ; Infections ; Inflammation ; Laboratories ; Membrane vesicle ; Mice, Inbred C3H ; Molecular weight ; Peptides ; Salmonella ; Salmonella enterica typhimurium ; Salmonella typhimurium ; Salmonella typhimurium - immunology ; Vaccine platform ; Vaccines</subject><ispartof>Vaccine, 2015-09, Vol.33 (38), p.5012-5019</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Sep 11, 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243</citedby><cites>FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26001432$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Laughlin, Richard C</creatorcontrib><creatorcontrib>Mickum, Megan</creatorcontrib><creatorcontrib>Rowin, Kristina</creatorcontrib><creatorcontrib>Adams, L. Garry</creatorcontrib><creatorcontrib>Alaniz, Robert C</creatorcontrib><title>Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract Membrane vesicles (MVs), discrete nano-structures produced from the outer membrane of Gram-negative bacteria such as Salmonella enterica Typhimurium ( S. Typhimurium), strongly activate dendritic cells (DCs), contain major antigens (Ags) recognized by Salmonella -specific B-cells and CD4+ T-cells, and provide protection against S. Typhimurium challenge in a mouse model. With this in mind, we hypothesized that alterations to the gene expression profile of bacteria will be reflected in the immunologic response to MVs. To test this, we assessed the ability of MVs from wild-type (WT) S. Typhimurium or a strain with a phenotype mimicking the intracellular-phase of S. Typhimurium (PhoPc ) to activate dendritic cells and initiate a strong inflammatory response. MVs, isolated from wild-type and PhoPc S. Typhimurium (WT MVs andPhoPc MVs, respectively) had pro-inflammatory properties consistent with the parental bacterial strains:PhoPc MVs were less stimulatory for DC activation in vitro and were impaired for subsequent inflammatory responses compared toWT MVs. Interestingly, the reduced pro-inflammatory properties ofPhoPc MVs did not completely rely on signals through TLR4, the receptor for LPS. Nonetheless, bothWT MVs andPhoPc MVs contained abundant immunogenic antigens capable of being recognized by memory-immune CD4+ T-cells from mice previously infected with S. Typhimurium. Furthermore, we analyzed a suite of pathogenic Gram-negative bacteria and their purified MVs for their ability to activate DCs and stimulate inflammation in a manner consistent with the known inflammatory properties of the parental strains, as shown for S. Typhimurium. Finally, analysis of the potential vaccine utility of S. Typhimurium MVs revealed their capacity to encapsulate an exogenous model antigen and stimulate antigen-specific CD4+ and CD8+ T-cell responses. Taken together, our results demonstrate the dependence of bacterial cell gene expression for MV immunogenicity and subsequent in vitro immunologic response, as well as their potential utility as a vaccine platform.</description><subject>Allergy and Immunology</subject><subject>Animals</subject><subject>Bacteria</subject><subject>Bacterial Vaccines - immunology</subject><subject>Bacteriology</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Cell-Derived Microparticles - immunology</subject><subject>Colleges & universities</subject><subject>Conflicts of interest</subject><subject>Dendritic cell</subject><subject>Dendritic Cells - immunology</subject><subject>Female</subject><subject>Gene expression</subject><subject>Genetic engineering</subject><subject>Gram-negative bacteria</subject><subject>Immunity, Innate</subject><subject>Immunogenicity</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Laboratories</subject><subject>Membrane vesicle</subject><subject>Mice, Inbred C3H</subject><subject>Molecular weight</subject><subject>Peptides</subject><subject>Salmonella</subject><subject>Salmonella enterica typhimurium</subject><subject>Salmonella typhimurium</subject><subject>Salmonella typhimurium - immunology</subject><subject>Vaccine platform</subject><subject>Vaccines</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNkk9r3DAQxUVpaTZ_PkKLoZdcvB1JlmxfWkJo0kKgh7SQU4QsjxNtLWkr2Qv59pXZbQu5tDAgGH56eqM3hLyhsKZA5fvNeqeNsR7XDKhYQy5avSAr2tS8ZII2L8kKmKzKisLdETlOaQMAgtP2NTliEjLN2YrcX4wTRuyLx5Cmwjo3eywipm3wCVMxhcKh66LO3R0ma8bcHGJwxa0eXfA4jrrQvi-uo3alxwc92R0WWz09hgf06ZS8GvSY8OxwnpDvV5--XX4ub75ef7m8uCmNEHQqKw201ig6bFH0HQ5c8F6Aboe6NQ00sjFN1bWi5azTYCSXsmYghnZomEFW8RNyvtfdxvBzxjQpZ5NZ3HkMc1K0pnXViorX_4OCFEJwltF3z9BNmKPPg2QK2mydUZopsadMDClFHNQ2Wqfjk6KglqzURh2yUktWCnLRxfPbg_rcOez_3PodTgY-7gHMP7ezGFUyFr3B3kY0k-qD_ecTH54pmNF6a_T4A58w_Z1GJaZA3S4Ls-wLFQCSC-C_AJQyu-o</recordid><startdate>20150911</startdate><enddate>20150911</enddate><creator>Laughlin, Richard C</creator><creator>Mickum, Megan</creator><creator>Rowin, Kristina</creator><creator>Adams, L. Garry</creator><creator>Alaniz, Robert C</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20150911</creationdate><title>Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens</title><author>Laughlin, Richard C ; Mickum, Megan ; Rowin, Kristina ; Adams, L. Garry ; Alaniz, Robert C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Allergy and Immunology</topic><topic>Animals</topic><topic>Bacteria</topic><topic>Bacterial Vaccines - immunology</topic><topic>Bacteriology</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Cell-Derived Microparticles - immunology</topic><topic>Colleges & universities</topic><topic>Conflicts of interest</topic><topic>Dendritic cell</topic><topic>Dendritic Cells - immunology</topic><topic>Female</topic><topic>Gene expression</topic><topic>Genetic engineering</topic><topic>Gram-negative bacteria</topic><topic>Immunity, Innate</topic><topic>Immunogenicity</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Laboratories</topic><topic>Membrane vesicle</topic><topic>Mice, Inbred C3H</topic><topic>Molecular weight</topic><topic>Peptides</topic><topic>Salmonella</topic><topic>Salmonella enterica typhimurium</topic><topic>Salmonella typhimurium</topic><topic>Salmonella typhimurium - immunology</topic><topic>Vaccine platform</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Laughlin, Richard C</creatorcontrib><creatorcontrib>Mickum, Megan</creatorcontrib><creatorcontrib>Rowin, Kristina</creatorcontrib><creatorcontrib>Adams, L. Garry</creatorcontrib><creatorcontrib>Alaniz, Robert C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Laughlin, Richard C</au><au>Mickum, Megan</au><au>Rowin, Kristina</au><au>Adams, L. Garry</au><au>Alaniz, Robert C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2015-09-11</date><risdate>2015</risdate><volume>33</volume><issue>38</issue><spage>5012</spage><epage>5019</epage><pages>5012-5019</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Abstract Membrane vesicles (MVs), discrete nano-structures produced from the outer membrane of Gram-negative bacteria such as Salmonella enterica Typhimurium ( S. Typhimurium), strongly activate dendritic cells (DCs), contain major antigens (Ags) recognized by Salmonella -specific B-cells and CD4+ T-cells, and provide protection against S. Typhimurium challenge in a mouse model. With this in mind, we hypothesized that alterations to the gene expression profile of bacteria will be reflected in the immunologic response to MVs. To test this, we assessed the ability of MVs from wild-type (WT) S. Typhimurium or a strain with a phenotype mimicking the intracellular-phase of S. Typhimurium (PhoPc ) to activate dendritic cells and initiate a strong inflammatory response. MVs, isolated from wild-type and PhoPc S. Typhimurium (WT MVs andPhoPc MVs, respectively) had pro-inflammatory properties consistent with the parental bacterial strains:PhoPc MVs were less stimulatory for DC activation in vitro and were impaired for subsequent inflammatory responses compared toWT MVs. Interestingly, the reduced pro-inflammatory properties ofPhoPc MVs did not completely rely on signals through TLR4, the receptor for LPS. Nonetheless, bothWT MVs andPhoPc MVs contained abundant immunogenic antigens capable of being recognized by memory-immune CD4+ T-cells from mice previously infected with S. Typhimurium. Furthermore, we analyzed a suite of pathogenic Gram-negative bacteria and their purified MVs for their ability to activate DCs and stimulate inflammation in a manner consistent with the known inflammatory properties of the parental strains, as shown for S. Typhimurium. Finally, analysis of the potential vaccine utility of S. Typhimurium MVs revealed their capacity to encapsulate an exogenous model antigen and stimulate antigen-specific CD4+ and CD8+ T-cell responses. Taken together, our results demonstrate the dependence of bacterial cell gene expression for MV immunogenicity and subsequent in vitro immunologic response, as well as their potential utility as a vaccine platform.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>26001432</pmid><doi>10.1016/j.vaccine.2015.05.014</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2015-09, Vol.33 (38), p.5012-5019 |
issn | 0264-410X 1873-2518 |
language | eng |
recordid | cdi_proquest_miscellaneous_1717495437 |
source | ScienceDirect Journals |
subjects | Allergy and Immunology Animals Bacteria Bacterial Vaccines - immunology Bacteriology CD4-Positive T-Lymphocytes - immunology CD8-Positive T-Lymphocytes - immunology Cell-Derived Microparticles - immunology Colleges & universities Conflicts of interest Dendritic cell Dendritic Cells - immunology Female Gene expression Genetic engineering Gram-negative bacteria Immunity, Innate Immunogenicity Infections Inflammation Laboratories Membrane vesicle Mice, Inbred C3H Molecular weight Peptides Salmonella Salmonella enterica typhimurium Salmonella typhimurium Salmonella typhimurium - immunology Vaccine platform Vaccines |
title | Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T22%3A14%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Altered%20host%20immune%20responses%20to%20membrane%20vesicles%20from%20Salmonella%20and%20Gram-negative%20pathogens&rft.jtitle=Vaccine&rft.au=Laughlin,%20Richard%20C&rft.date=2015-09-11&rft.volume=33&rft.issue=38&rft.spage=5012&rft.epage=5019&rft.pages=5012-5019&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2015.05.014&rft_dat=%3Cproquest_cross%3E3798264231%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1709551211&rft_id=info:pmid/26001432&rfr_iscdi=true |